The advent of biological drugs has revolutionized the management of various pediatric rheumatologic diseases, primarily juvenile idiopathic arthritis. These drugs enable better disease control and ...

In a new study, researchers reviewed the advancements and ongoing challenges in the development of biologic therapies and disease prognosis of pediatric rheumatic diseases over the past 25 years, ...

Patients with rheumatic heart disease who took the heart failure drug digoxin were 18% less likely to die or experience ...

Rheumatic heart disease is a serious complication of Group A Streptococcus infection. It can cause damage to the valves in your heart and may cause severe heart problems in the future. Rheumatic heart ...

Objectives To determine the prevalence of depressive and anxiety symptoms among young people 7 years and 9 years after ...

Patients with rheumatic heart disease who took the heart failure drug digoxin were 18% less likely to die or experience ...

Please provide your email address to receive an email when new articles are posted on . ORLANDO, Fla. — Although rheumatic diseases must be considered in a differential diagnosis of autoimmune ...

Tocilizumab is a humanized recombinant antibody that binds to IL-6 receptor, and inhibits the downstream signaling of IL-6 and thus its proinflammatory effects. Serum and synovial fluid levels of IL-6 ...

This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. (NewsNation) — Six in 10 adults will live ...